CVS Health Corporation

75.88+0.1000+0.13%Vol 8.48M1Y Perf 21.40%
Apr 16th, 2021 16:00 DELAYED
BID75.67 ASK75.91
Open76.15 Previous Close75.78
Pre-Market- After-Market75.80
 - -  -0.08 -0.11%
Target Price
88.25 
Analyst Rating
Moderate Buy 1.59
Potential %
16.30 
Finscreener Ranking
★★★     49.41
Insiders Trans % 3/6/12 mo.
-80/-90/-66 
Value Ranking
★★+     48.85
Insiders Value % 3/6/12 mo.
-99/-99/-97 
Growth Ranking
★★+     50.60
Insiders Shares Cnt. % 3/6/12 mo.
-99/-99/-96 
Income Ranking
★+     36.62
Market Cap99.51B 
Earnings Rating
Sell
Price Range Ratio 52W %
93.83 
Earnings Date
4th May 2021

Today's Price Range

75.5676.20

52W Range

55.3677.23

5 Year PE Ratio Range

-89.2023.00

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
2.44%
1 Month
2.53%
3 Months
-0.50%
6 Months
28.42%
1 Year
21.40%
3 Years
13.07%
5 Years
-25.15%
10 Years
125.82%

TickerPriceChg.Chg.%
CVS75.880.10000.13
AAPL134.16-0.3400-0.25
GOOG2 297.761.10000.05
MSFT260.741.24000.48
XOM56.66-0.3200-0.56
WFC43.841.60003.79
JNJ162.241.85001.15
FB306.18-1.6400-0.53
GE13.39-0.1600-1.18
JPM153.301.13000.74
Financial StrengthValueIndustryS&P 500US Markets
0.50
0.90
0.53
1.23
4.40
Leverage Ratio 3.40
ProfitabilityValueIndustryS&P 500US Markets
18.30
4.70
6.40
3.10
2.55
RevenueValueIndustryS&P 500US Markets
201.95B
153.87
14.82
11.30
DividendsValueIndustryS&P 500US Markets
2.69
2.00
0.00
6.70
Payout ratio33.00
Earnings HistoryEstimateReportedSurprise %
Q04 20201.241.304.84
Q03 20201.341.6623.88
Q02 20201.932.6436.79
Q01 20201.631.9117.18
Q04 20191.681.732.98
Q03 20191.771.843.95
Q02 20191.701.8911.18
Q01 20191.501.628.00
Earnings Per EndEstimateRevision %Trend
3/2021 QR1.69-7.65Negative
6/2021 QR1.873.31Positive
12/2021 FY7.52-0.13Negative
12/2022 FY8.05-0.86Negative
Next Report Date4th May 2021
Estimated EPS Next Report1.70
Estimates Count10
EPS Growth Next 5 Years %6.70
Volume Overview
Volume8.48M
Shares Outstanding1.31B
Trades Count39.44K
Dollar Volume482.49M
Avg. Volume6.84M
Avg. Weekly Volume4.52M
Avg. Monthly Volume6.11M
Avg. Quarterly Volume6.64M

CVS Health Corporation (NYSE: CVS) stock closed at 75.88 per share at the end of the most recent trading day (a 0.13% change compared to the prior day closing price) with a volume of 8.51M shares and market capitalization of 99.51B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 300000 people. CVS Health Corporation CEO is Karen S. Lynch.

The one-year performance of CVS Health Corporation stock is 21.4%, while year-to-date (YTD) performance is 11.1%. CVS stock has a five-year performance of -25.15%. Its 52-week range is between 55.36 and 77.23, which gives CVS stock a 52-week price range ratio of 93.83%

CVS Health Corporation currently has a PE ratio of 13.50, a price-to-book (PB) ratio of 1.40, a price-to-sale (PS) ratio of 0.48, a price to cashflow ratio of 6.10, a PEG ratio of 2.32, a ROA of 3.04%, a ROC of 6.56% and a ROE of 10.34%. The company’s profit margin is 2.55%, its EBITDA margin is 6.40%, and its revenue ttm is $201.95 Billion , which makes it $153.87 revenue per share.

Of the last four earnings reports from CVS Health Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.70 for the next earnings report. CVS Health Corporation’s next earnings report date is 04th May 2021.

The consensus rating of Wall Street analysts for CVS Health Corporation is Moderate Buy (1.59), with a target price of $88.25, which is +16.30% compared to the current price. The earnings rating for CVS Health Corporation stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

CVS Health Corporation has a dividend yield of 2.69% with a dividend per share of $2.00 and a payout ratio of 33.00%.

CVS Health Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 8.24, ATR14 : 1.66, CCI20 : 107.68, Chaikin Money Flow : 0.00, MACD : 0.85, Money Flow Index : 49.24, ROC : -0.26, RSI : 58.53, STOCH (14,3) : 72.27, STOCH RSI : 1.00, UO : 59.47, Williams %R : -27.73), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of CVS Health Corporation in the last 12-months were: Alan Lotvin (Buy at a value of $631 350), Alan Lotvin (Option Excercise at a value of $1 716 346), Alan Lotvin (Sold 40 112 shares of value $2 937 020 ), Alan M. Lotvin (Buy at a value of $631 350), Alan M. Lotvin (Option Excercise at a value of $3 432 692), Alan M. Lotvin (Sold 65 948 shares of value $4 874 720 ), Edward J. Ludwig (Buy at a value of $216 000), Eva C. Boratto (Option Excercise at a value of $1 402 743), Eva C. Boratto (Sold 18 882 shares of value $1 410 107 ), James D. Clark (Option Excercise at a value of $397 452), James D. Clark (Sold 11 854 shares of value $829 360 ), Jonathan C. Roberts (Option Excercise at a value of $5 455 337), Jonathan C. Roberts (Sold 73 433 shares of value $5 470 024 ), Jonathan E. Mayhew (Sold 21 112 shares of value $1 372 280 ), Joshua Flum (Option Excercise at a value of $750 242), Joshua Flum (Sold 21 460 shares of value $1 502 200 ), Larry J. Merlo (Option Excercise at a value of $49 877 858), Larry J. Merlo (Sold 667 086 shares of value $50 136 870 ), Lisa Bisaccia (Option Excercise at a value of $3 740 798), Lisa Bisaccia (Sold 50 354 shares of value $3 877 258 ), Thomas M. Moriarty (Option Excercise at a value of $4 676 035), Thomas M. Moriarty (Sold 112 154 shares of value $8 442 104 ), Troyen A. Brennan (Option Excercise at a value of $4 052 519), Troyen A. Brennan (Sold 58 896 shares of value $4 417 200 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
10 (62.50 %)
10 (62.50 %)
11 (61.11 %)
Moderate Buy
2 (12.50 %)
2 (12.50 %)
2 (11.11 %)
Hold
4 (25.00 %)
4 (25.00 %)
5 (27.78 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.59
Moderate Buy
1.59
Moderate Buy
1.64

CVS Health Corporation

CVS Health Corp provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing about 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with over 23 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

CEO: Karen S. Lynch

Telephone: +1 401 765-1500

Address: One CVS Drive, Woonsocket 02895, RI, US

Number of employees: 300 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

58%42%

Bearish Bullish

59%41%

Bearish Bullish

65%35%

News

Stocktwits